NEUROCRINE BIOSCIENCES INC (NBIX) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.
Key numbers for NEUROCRINE BIOSCIENCES INC (NBIX): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.
AllSight quality score: 72/100 — a percentile rank of NEUROCRINE BIOSCIENCES INC’s fundamentals against Manufacturing peers, weakest on valuation. A quality ranking, not a price prediction.
| Market cap | $14.3B |
| P / E | 20.3× |
| P / S | 4.2× |
| EV / EBITDA | 16.7× |
| Gross margin | 98.0% |
| Operating margin | 22.7% |
| Net margin | 20.9% |
| Return on equity | 19.1% |
| ROIC | 17.1% |
| Revenue growth | 34.4% |
| Debt / equity | 0.0× |
| Dividend yield | 0.0% |
Is NEUROCRINE BIOSCIENCES INC overvalued? P/E looks undervalued vs its 5-year range; P/S looks undervalued vs its 5-year range; EV/EBITDA looks undervalued vs its 5-year range; P/B looks undervalued vs its 5-year range.
Independent of the events above — derived from NEUROCRINE BIOSCIENCES INC’s own financial statements and shown as context, never as advice.
About AllSight · Editorial standards & method · Contact